Professor Roger Walker appointed Chief Pharmaceutical Officer for Wales
27 November 2010
Roger Walker
Dr Tony Jewell, the Chief Medical Officer for Wales, announced on Friday, 26 November that Professor Roger Walker had been appointed the new Chief Pharmaceutical Officer for Wales on a five year secondment from Cardiff University.
Professor Roger Walker is currently a Professor of Pharmaceutical Public Health in the Welsh School of Pharmacy and Consultant at Public Health Wales. Roger has been at the Welsh School of Pharmacy since 1990 and for 10 years was also Director of Pharmaceutical Public Health to Gwent Health Authority . He will take up his new post with the Welsh Assembly Government early in the New Year, but will maintain some research interests within the University.
Dr Jewell said: “I am pleased to announce the appointment of Professor Walker as our new Chief Pharmaceutical Officer for Wales. Roger brings to the role a background in Clinical Pharmacy and Pharmaceutical Public Health working in the NHS. He has a strong academic record in teaching and research with an established reputation across the UK and beyond."
Dr Jewell went on to thank Jeremy Savage for the commitment and professionalism he had shown as Acting Chief Pharmaceutical Adviser following the ill health and retirement of Carwen Wynne Howells. “Jeremy played a crucial role during the swine flu pandemic and will continue to advise me and the Assembly Government on pharmaceutical issues.”
Health Minister Edwina Hart in her endorsement said: “I’d like to congratulate Professor Walker on his appointment. He will build on Carwen and Jeremy’s work to develop and enhance the role of pharmacists across Wales.”
Professor Walker said: "I am delighted to have been appointed and look forward to working with the Welsh Assembly Government on the many aspects of pharmaceutical policy and practice. The integrated NHS in Wales, Public Health Wales and the professional advisory mechanisms give us a wonderful opportunity for developing joined up policies and practice as part of the five-year strategy which will be to the benefit of patients and deliver best value in medicines management."
.
For further background see:
Prof Roger Walker
